AA

Akhila Arya Perumangote Vasudevan

Active Director Designated Partner DIN 08664637
DIN 08664637 First appointment Jan 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Akhila Arya Perumangote Vasudevan

Data last updated:

Akhila Arya Perumangote Vasudevan is a Designated Partner at Cholamana Llp (since 2020). The company operates in Healthcare.

DIN 08664637
Primary Designation Designated Partner
Industry Healthcare
First Appointment 10 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cholamana Llp AAR-5692
Designated Partner10 Jan 20202020Active

Board colleagues of Akhila Arya Perumangote Vasudevan

NameDINCompanyDesignation
Dileep Cholayil Unnikrishnan08664636Cholamana LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cholamana Llp
Premium access

Shareholding and investment profile for Akhila Arya Perumangote Vasudevan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akhila Arya Perumangote Vasudevan

Akhila Arya Perumangote Vasudevan currently holds 1 directorship: Cholamana Llp (Designated Partner, since 10 Jan 2020).

Akhila Arya Perumangote Vasudevan was first appointed on 10 Jan 2020 as Designated Partner at Cholamana Llp.

The current boards of Akhila Arya Perumangote Vasudevan's companies include Dileep Cholayil Unnikrishnan (Cholamana Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available